What dose of liquid iron provides the same elemental iron as a 325 mg ferrous sulfate tablet for a patient with aphasia and a history of cerebrovascular accident (stroke)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Liquid Iron Dosing Equivalent to Ferrous Sulfate 325 mg

For a patient with aphasia and stroke history requiring liquid iron, administer 65 mg of elemental iron daily, which is the equivalent of one 325 mg ferrous sulfate tablet. 1

Elemental Iron Content

Ferrous sulfate 325 mg contains 65 mg of elemental iron 1. This is the critical conversion you need to know when switching formulations. The 325 mg refers to the total salt weight, not the actual absorbable iron content.

Available Liquid Iron Formulations

When selecting a liquid iron preparation, you have several options 2:

  • Ferrous sulfate liquid: 65 mg elemental iron per dose equivalent
  • Ferrous gluconate liquid: Contains 27-38 mg elemental iron per typical dose (would need approximately 2 doses to match)
  • Polysaccharide-iron complex liquid: Varies by product—check the label for elemental iron content
  • Ferrous bisglycinate liquid: 25 mg elemental iron per typical dose (would need approximately 2.5 doses to match)

The most straightforward conversion is ferrous sulfate liquid dosed to provide 65 mg elemental iron once daily.

Dosing Considerations for This Patient

Optimal Administration

For maximum absorption 3:

  • Administer in the morning on an empty stomach
  • Give with approximately 100 mg vitamin C (as a tablet or with citrus juice like orange juice)
  • If vitamin C unavailable, give with plain water
  • Avoid tea, coffee, milk, or food within 1 hour of dosing
  • Patient should remain upright for 30-60 minutes after administration to prevent pill esophagitis (less relevant for liquid but still good practice)

Lower Dose Alternative

Recent evidence suggests lower doses may improve tolerability and absorption 4. Consider 15-50 mg elemental iron daily if the patient experiences gastrointestinal side effects 5. Studies in elderly patients show that 15 mg daily can effectively resolve iron deficiency anemia with significantly fewer adverse effects compared to 150 mg daily 5.

Alternate-Day Dosing Option

If gastrointestinal intolerance develops, alternate-day dosing may improve tolerability while maintaining efficacy 4. This would mean giving 130 mg elemental iron (double dose) every other day, though recent pregnancy data suggests daily dosing may be slightly more effective 6.

Monitoring Response

Expect hemoglobin to increase by 1 g/dL within 2 weeks if the patient is adherent and absorbing the iron 2. Ferritin should increase within 1 month 2. If these parameters are not met:

  • Assess for non-adherence (often due to side effects)
  • Consider malabsorption
  • Evaluate for ongoing blood loss
  • Switch to intravenous iron if oral therapy fails 2

Special Considerations for Stroke Patients

The patient's history of stroke (aCVA) and aphasia primarily affects their ability to communicate side effects rather than iron absorption. Ensure a caregiver monitors for:

  • Gastrointestinal complaints (constipation, diarrhea, nausea, abdominal discomfort)
  • Black stools (expected and benign)
  • Signs of non-adherence

If the patient is on anticoagulation or antiplatelet therapy (common post-stroke), be vigilant about monitoring for gastrointestinal bleeding, which could counteract iron supplementation 4.

Cost and Practical Considerations

Ferrous sulfate liquid is the least expensive option at $0.30-$4.50 per 30 doses 2. This makes it the most practical first-line choice unless gastrointestinal intolerance develops, in which case ferrous bisglycinate may be better tolerated 7, 8.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.